Carlisle Companies (CSL) Upgraded to Market Perform at FBR Capital

Carlisle Companies (CSL) has been upgraded today by the securities research analysts at investment firm FBR Capital which upgraded Carlisle from a “under perform” rating to “market perform.”  FBR Capital also raised their performance outlook for CSL and adjusted their price target from $35 to $45 dollars.  FBR noted that their rating change is based on Carlisle’s impressive accretion after their recent acquisition of Hawk.  Additionally, company fiscal year 2011 & 2012 estimates are moved in-line with consensus.

After stumbling into 2011 there has been nothing but upside to shares of CSL.  Overall positive sentiment underlies CSL as it keeps setting higher high one after another, coupled with higher lows.  Noteworthy, however, is CSL’s recent stint of consolidation which begins with the standing 52-week high of $50.60 which a run was made on during a bullish drive in June.  CSL has been under a pullback since then, though.

Carlisle is slated to release their next earnings report on July 26th, 2011, and the current consensus EPS estimate is expected to be 91 cents.  Their last earnings report was released on April 26th, 2011, and announced EPS of 37 cents with revenue totaling $693.6 million which was up 26.7% year to year.  CSL is currently trading between its 50 & 200-day moving averages and 2011 is an up  year for the company.

Carlisle is a diversified manufacturing company consisting of five segments which manufacture and distribute a broad range of products.  The company has market capitalization of $2,873,244,340 and 61,211,000 shares outstanding.  CSL has a 52-week high of $50.60 with the low being $27.97 dollars.

Latest News

UnitedHealth Group  Price Target Increased to $300.00 by Analysts at BMO Capital Markets
UnitedHealth Group Price Target Increased to $300.00 by Analysts at BMO Capital Markets
VICI Properties  Lifted to “Buy” at Zacks Investment Research
VICI Properties Lifted to “Buy” at Zacks Investment Research
TJX Companies  Stock Rating Upgraded by ValuEngine
TJX Companies Stock Rating Upgraded by ValuEngine
TransDigm Group  Upgraded by ValuEngine to “Buy”
TransDigm Group Upgraded by ValuEngine to “Buy”
Castlight Health Inc  Given Average Recommendation of “Hold” by Analysts
Castlight Health Inc Given Average Recommendation of “Hold” by Analysts
Relx  Earning Favorable News Coverage, Report Shows
Relx Earning Favorable News Coverage, Report Shows


© 2006-2018 Ticker Report. Google+.